Balsalazide sodium hydrate(Synonyms: 巴柳氮钠水合物; Balsalazide disodium dihydrate)

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Balsalazide sodium hydrate (Synonyms: 巴柳氮钠水合物; Balsalazide disodium dihydrate)

Balsalazide sodium hydrate 可通过调节 IL-6/STAT3 通路来发挥相关的抑癌作用。

Balsalazide sodium hydrate(Synonyms: 巴柳氮钠水合物; Balsalazide disodium dihydrate)

Balsalazide sodium hydrate Chemical Structure

CAS No. : 150399-21-6

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

Balsalazide sodium hydrate 的其他形式现货产品:

Balsalazide

生物活性

Balsalazide sodium hydrate could suppress colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway.

IC50 & Target[1][2]

IL-6

 

STAT3

 

体内研究
(In Vivo)

At the endpoint, the protein production of MIP-1β, MCP-1, IL-6, and IL-10 in the colon tissues decrease in concordance with the plasma concentrations of the cytokines. The drug-treated groups reveal lower expression of p-STAT3 compared to the CAC group. In addition, BCL2 decreases and BAX increases markedly in the BSZ+VSL#3 group[1]. Balsalazide is a new 5-aminosalicylic acid (5-ASA) containing prodrug[2].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial

分子量

437.31

Formula

C17H17N3Na2O8
CAS 号

150399-21-6
中文名称

巴柳氮钠水合物
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Do EJ, et al. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3. J Gastroenterol Hepatol. 2016 Aug;31(8):1453-61.

    [2]. Kruis W, et al. Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses. Gut, 2001. 49(6): p. 783-789.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务